
Recent medical research identifies a new therapeutic target involving the thinning of sugar coatings on cancer cells to improve the immune system's ability to attack and destroy tumours.
The findings are part of broader health updates, including reports that Ebola cases in the Democratic Republic of Congo have surpassed 4,000 as the outbreak continues to intensify.
Other health developments include the impact of updated hypertension guidelines on Indian patients and the use of multi-omics to identify specific targets for treating gallbladder cancer.